HomeNewsGlobal Pharma

BioPulse Solutions Marks its Inaugural Year with INR 360 Million Valuation

BioPulse Solutions Marks its Inaugural Year with INR 360 Million Valuation

BioPulse Solutions Pvt Ltd. announces significant milestones and achievements at the start of 2024 as it continues to bring in innovations in bioprocessing technologies that would significantly benefit the biopharma industry. BioPulse Solutions set out with the initial goals of introducing innovative solutions in Single-Use Bioprocessing Technology, redefining customization for the industry.

Having inaugurated the state-of-the-art certified Class 7 & 8 cleanroom facilities at Hyderabad, in October 2023, the company looks to build end-to-end single-use bioprocessing solutions for the pharmaceutical and biopharmaceutical customers. BioPulse Solutions also has a stainless steel bioprocessing customisation and engineering facility at Nashik.

BioPulse Solutions' vision revolves around 'Enabling Solutions for a better tomorrow' that transform their pain areas into performance centers.” The company prides itself on being India's first open architecture single-use bioprocessing integrator, offering unique hybrid solutions that seamlessly integrate conventional stainless-steel process systems with the latest single-use technologies. This approach provides unparalleled flexibility and choice for customers.

Piyush Jain, CEO BioPulse Solutions had this to say about the achievement. "We are thrilled to announce that BioPulse Solutions Pvt Ltd. has reached an astounding valuation of INR 360 million in our latest investment round. This achievement is a testament to our dedication, innovation, and the incredible team that makes it all possible. As India's First Open Architecture Single-Use Bioprocessing Integrator, we have consistently disrupted industry norms and set new benchmarks. This financial achievement not only validates our unique approach but propels us toward a future of even greater impact and innovation in the Bio-Pharma and bioprocess industry. We extend our heartfelt gratitude to our investors, partners, and the entire BioPulse community for their unwavering support as we continue to shape the future of bioprocessing technologies."

Read more on:
More news about: global pharma | Published by Manvi | January - 12 - 2024 | 1013

Last news about this category


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members